SCHEMBL28973015

SCHEMBL28973015

COc1cc(F)c([N+](=O)[O-])cc1Nc1nccc(-n2cc(C=O)c3ccc(F)cc32)n1

nearest known ligand 0.38

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
EGFR P00533 14/20 0.38
KDR P35968 2/20 0.36
PTK2 Q05397 1/20 0.33
CCNT1 O60563 1/20 0.33
CDK9 P50750 1/20 0.33
ALDH1A1 P00352 2/20 0.33
KDM4E B2RXH2 1/20 0.32
CYP3A4 P08684 1/20 0.32
MAPT P10636 1/20 0.32
ALOX15 P16050 1/20 0.32
PRKDC P78527 1/20 0.32
HSD17B10 Q99714 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30175537 1.00 EGFR (0.38) EGFRKDRPTK2CCNT1CDK9
SCHEMBL30175544 0.89 CCNT1 (0.43) EGFRCCNT1CDK9ALDH1A1
SCHEMBL28972998 0.89 CCNT1 (0.43) EGFRCCNT1CDK9ALDH1A1
SCHEMBL19089534 0.83 CDC7 (0.44) EGFRKDRPTK2CCNT1CDK9
SCHEMBL35210303 0.83 CDC7 (0.44) EGFRKDRPTK2CCNT1CDK9
SCHEMBL28973001 0.83 CCNT1 (0.37) EGFRCCNT1CDK9ALDH1A1MAPT
SCHEMBL30175534 0.83 CCNT1 (0.37) EGFRCCNT1CDK9ALDH1A1MAPT
SCHEMBL17670296 0.80 EGFR (0.37) EGFRKDRALDH1A1KDM4ECYP3A4
SCHEMBL31030279 0.80 EGFR (0.37) EGFRKDRALDH1A1KDM4ECYP3A4
SCHEMBL19337104 0.80 EGFR (0.54) EGFRKDRCCNT1CDK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115701429-B 4- (1H-indol-1-yl) pyrimidine-2-amino derivative, and preparation method and application thereof 上海和誉生物医药科技有限公司 2024-03-12 CN disclosed
CN-115701429-A 4- (1H-indole-1-yl) pyrimidine-2-amino derivative and preparation method and application thereof 上海和誉生物医药科技有限公司 2023-02-10 CN disclosed